Sılan, C. Et Al. 2012. The prevelance of VKORC1 1639 G A and CYP2C9 2 3 genotypes in patients that requiring anticoagulant therapy in Turkish population. European Human Genetics Conference , (Nuremberg, Germany), 356.

Sılan, C., Doğan, Ö. T., Sılan, F., Kukulgüven, F. M., Aşgün, H. F., Özdemir, S., ... Uludağ, A.(2012). The prevelance of VKORC1 1639 G A and CYP2C9 2 3 genotypes in patients that requiring anticoagulant therapy in Turkish population . European Human Genetics Conference (pp.356). Nuremberg, Germany

Sılan, COŞKUN Et Al. "The prevelance of VKORC1 1639 G A and CYP2C9 2 3 genotypes in patients that requiring anticoagulant therapy in Turkish population," European Human Genetics Conference, Nuremberg, Germany, 2012

Sılan, COŞKUN Et Al. "The prevelance of VKORC1 1639 G A and CYP2C9 2 3 genotypes in patients that requiring anticoagulant therapy in Turkish population." European Human Genetics Conference , Nuremberg, Germany, pp.356, 2012

Sılan, C. Et Al. (2012) . "The prevelance of VKORC1 1639 G A and CYP2C9 2 3 genotypes in patients that requiring anticoagulant therapy in Turkish population." European Human Genetics Conference , Nuremberg, Germany, p.356.

@conferencepaper{conferencepaper, author={COŞKUN SILAN Et Al. }, title={The prevelance of VKORC1 1639 G A and CYP2C9 2 3 genotypes in patients that requiring anticoagulant therapy in Turkish population}, congress name={European Human Genetics Conference}, city={Nuremberg}, country={Germany}, year={2012}, pages={356} }